New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S4772

Introduced

10/27/25

Refer

10/27/25

Classifies 7 Hydroxymitragynine as Schedule I drug.

No companion bills found.

Classifies 7 Hydroxymitragynine as Schedule I drug.

Classifies 7 Hydroxymitragynine as Schedule I drug and bans sale of products containing substance.

Makes 7-hydroxymitragynine in certain amounts a Schedule I controlled substance

Kratom classified as a Schedule II controlled substance.

Kratom classification as a Schedule II controlled substance

Establishes tianeptine as Schedule II controlled dangerous substance.

Controlled substances; mitragynine and hydroxymitragynine (7-OH) are Schedule I; provide

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

Adds 7-Hydroxymitragynine, including its salts, isomers and salts of isomers, as a schedule 1 controlled substance.

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

No similar bills found.